SS
AQST icon

SBI Securities’s Aquestive Therapeutics AQST Stock Holding History

SBI Securities’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Sell
3,632
-14,173
-80% -$59.6K ﹤0.01% 1647
2026
Q1 		$73.9K Sell
17,805
-1,593
-8% -$6.46K ﹤0.01% 952
2025
Q4 		$125K Sell
19,398
-41
-0.2% -$255 ﹤0.01% 767
2025
Q3 		$109K Sell
19,439
-30,360
-61% -$131K ﹤0.01% 830
2025
Q2 		$165K Buy
49,799
+2,246
+5% +$6.44K ﹤0.01% 650
2025
Q1 		$138K Buy
47,553
+15,205
+47% +$46K ﹤0.01% 642
2024
Q4 		$115K Buy
+32,348
New +$149K ﹤0.01% 715

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

SBI Securities's AQST Position: Q2 2026 in Review

SBI Securities reduced its Aquestive Therapeutics (AQST) stake by 80% in Q2 2026, selling an estimated $59.6K and leaving 3,632 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

SBI Securities first reported a position in AQST in Q4 2024 and has held it in 7 quarters since. The position peaked at $165K in Q2 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • SBI Securities held 3,632 shares of Aquestive Therapeutics worth $15.1K as of Q2 2026.
  • SBI Securities sold 14,173 Aquestive Therapeutics shares in Q2 2026, an estimated $59.6K.
  • Aquestive Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1647 holding.
  • SBI Securities first reported a position in Aquestive Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Aquestive Therapeutics position peaked at $165K in Q2 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.